Phase I Dose Escalation Study of BAY94-9343 Given by Intravenous Infusion Every 3 Weeks in Japanese Subjects With Advanced Malignancies
Clinical trial NCT02485119 · COMPLETED
Trial details
- NCT number
- NCT02485119
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-14
- Primary completion
- 2017-04-28
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.